Inventor

VAKKALANKA SWAROOP K

CH34 patents

⚠️ This page may combine multiple inventors who share the name “VAKKALANKA SWAROOP K”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

VAKKALANKA SWAROOP K

RHIZEN PHARMACEUTICALS SA

Pharmaceutical compositions containing a PDE4 inhibitor and a PI3 delta or dual PI3 delta-gamma kinase inhibitor

Selective PI3K delta inhibitors

Selective PI3K delta inhibitors

Forms of a PI3K delta selective inhibitor for use in pharmaceutical formulations

Forms of a PI3K delta selective inhibitor for use in pharmaceutical formulations

Kinase modulators

Compounds as modulators of protein kinases

Glutaminase inhibitors

Kinase modulators

Dual selective PI3 delta and gamma kinase inhibitors

Pharmaceutical compositions containing a PDE4 inhibitor and a PI3 delta or dual PI3 delta-gamma kinase inhibitor

Intermediates useful in the synthesis of compounds as modulators of protein kinases

Forms of a PI3K delta selective inhibitor for use in pharmaceutical formulations

Modulators of calcium release-activated calcium channel

Process for preparation of optically pure and optionally substituted 2-(1-hydroxy-alkyl)-chromen-4-one derivatives and their use in preparing pharmaceuticals

Kinase modulators

Pharmaceutical compositions containing a PDE4 inhibitor and a PI3 delta or dual PI3 delta-gamma kinase inhibitor

Pharmaceutical compositions containing a PDE4 inhibitor and a PI3 delta or dual PI3 delta-gamma kinase inhibitor

Dual selective P13 delta and gamma kinase inhibitors

Modulators of calcium release-activated calcium channel

Substituted chromenones as modulators of protein kinases

Modulators of calcium release-activated calcium channel

Selective dual inhibitors of PI3 delta and gamma protein kinases

Modulators of calcium release-activated calcium channel

Compounds as modulators of GPR-119

Immunomodulator and anti-inflammatory compounds

Selective dual inhibitors of PI3 delta and gamma protein kinases

Glutaminase inhibitors

Process for preparation of optically pure and optionally substituted 2-(1-hydroxy-alkyl)-chromen-4-one derivatives and their use in preparing pharmaceuticals

Process for preparation of optically pure and optionally substituted 2-(1-hydroxy-alkyl)-chromen-4-one derivatives and their use in preparing pharmaceuticals

INCOZEN THERAPEUTICS PVT LTD

Methods of treating autoimmune, respiratory and inflammatory disorders by inhalation of roflumilast N-oxide

3,5-disubstituted-3H-imidazo[4,5-B]pyridine and 3,5-disubstituted-3H-[1,2,3]triazolo[4,5-B] pyridine compounds as modulators of protein kinases

Methods of treating autoimmune, respiratory and inflammatory disorders by inhalation of roflumilast N-oxide

3,5-disubstituted-3H-imidazo[4,5-B]pyridine and 3,5-disubstituted-3H-[1,2,3]triazolo[4,5-B] pyridine compounds as modulators of protein kinases